Filtered By:
Vaccination: Covid Vaccine
This page shows you your search results in order of relevance. This is page number 10.
Order by Relevance | Date
Total 848 results found since Jan 2013.
Effectiveness of Coronavirus Vaccines against Syndrome Coronavirus 2 (SARS-CoV-2) and Its New Variants
Iran J Allergy Asthma Immunol. 2021 Dec 8;20(6):647-671. doi: 10.18502/ijaai.v20i6.8016.ABSTRACTThe widespread outbreak of coronavirus disease 2019 in late 2019 caused many people worldwide to die or suffer from certain clinical complications even after the recovery. The virus has many social and economic adverse effects. Studies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have specified that spike, surface glycoprotein antigen, is considered as a major target to stimulate the immune system. This glycoprotein binds to the angiotensin-converting enzyme 2 on the surface of human cells especially lung epit...
Source: Iranian Journal of Allergy, Asthma and Immunology - December 18, 2021 Category: Allergy & Immunology Authors: Afshin Abdi Ghavidel Mahbubeh Rojhannezhad Bahram Kazemi Mojgan Bandehpour Source Type: research
Hypersentivity reactions to COVID-19 vaccines: a case of Eosinophilic pneumonia following Sinovac/CoronaVac vaccination
Eur Ann Allergy Clin Immunol. 2022 Feb 11. doi: 10.23822/EurAnnACI.1764-1489.247. Online ahead of print.ABSTRACTHypersensitivity reactions has been reported with COVID-19 vaccines. Acute eosinophilic pneumonia has not been reported yet after Sinovac/CoronaVac vaccine. A 73-year-old woman presented with maculopapular rash, cough and dyspnea following Sinovac/CoronaVac injection. The complete blood count (CBC) indicated eosinophilia and further evaluation of the eosinophilia with CT and bronchoscopy confirmed a diagnosis of acute eosinophilic pneumonia. After methylprednisolone therapy, her rash resolved with marked improvem...
Source: European Annals of Allergy and Clinical Immunology - February 14, 2022 Category: Allergy & Immunology Authors: A B Ozturk B Çağlayan M Kapmaz I Çalık S Tekin S İliaz P F ırat Source Type: research
Effectiveness of Coronavirus Vaccines against Syndrome Coronavirus 2 (SARS-CoV-2) and Its New Variants
Iran J Allergy Asthma Immunol. 2021 Dec 8;20(6):647-671. doi: 10.18502/ijaai.v20i6.8016.ABSTRACTThe widespread outbreak of coronavirus disease 2019 in late 2019 caused many people worldwide to die or suffer from certain clinical complications even after the recovery. The virus has many social and economic adverse effects. Studies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have specified that spike, surface glycoprotein antigen, is considered as a major target to stimulate the immune system. This glycoprotein binds to the angiotensin-converting enzyme 2 on the surface of human cells especially lung epit...
Source: Iranian Journal of Allergy, Asthma and Immunology - December 18, 2021 Category: Allergy & Immunology Authors: Afshin Abdi Ghavidel Mahbubeh Rojhannezhad Bahram Kazemi Mojgan Bandehpour Source Type: research
Hypersentivity reactions to COVID-19 vaccines: a case of Eosinophilic pneumonia following Sinovac/CoronaVac vaccination
Eur Ann Allergy Clin Immunol. 2022 Feb 11. doi: 10.23822/EurAnnACI.1764-1489.247. Online ahead of print.ABSTRACTHypersensitivity reactions has been reported with COVID-19 vaccines. Acute eosinophilic pneumonia has not been reported yet after Sinovac/CoronaVac vaccine. A 73-year-old woman presented with maculopapular rash, cough and dyspnea following Sinovac/CoronaVac injection. The complete blood count (CBC) indicated eosinophilia and further evaluation of the eosinophilia with CT and bronchoscopy confirmed a diagnosis of acute eosinophilic pneumonia. After methylprednisolone therapy, her rash resolved with marked improvem...
Source: European Annals of Allergy and Clinical Immunology - February 14, 2022 Category: Allergy & Immunology Authors: A B Ozturk B Çağlayan M Kapmaz I Çalık S Tekin S İliaz P F ırat Source Type: research
Effectiveness of Coronavirus Vaccines against Syndrome Coronavirus 2 (SARS-CoV-2) and Its New Variants
Iran J Allergy Asthma Immunol. 2021 Dec 8;20(6):647-671. doi: 10.18502/ijaai.v20i6.8016.ABSTRACTThe widespread outbreak of coronavirus disease 2019 in late 2019 caused many people worldwide to die or suffer from certain clinical complications even after the recovery. The virus has many social and economic adverse effects. Studies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have specified that spike, surface glycoprotein antigen, is considered as a major target to stimulate the immune system. This glycoprotein binds to the angiotensin-converting enzyme 2 on the surface of human cells especially lung epit...
Source: Iranian Journal of Allergy, Asthma and Immunology - December 18, 2021 Category: Allergy & Immunology Authors: Afshin Abdi Ghavidel Mahbubeh Rojhannezhad Bahram Kazemi Mojgan Bandehpour Source Type: research
Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions
We thank de Chaisemartin et al1 for their correspondence in regard to our manuscript, “Coronavirus disease 2019 vaccine hypersensitivity evaluated with vaccine and excipient allergy skin testing.”2 De Chaisemartin et al1 elucidate their findings of transient elevation of serum histamine levels in 1 of 5 patients with an aphylaxis after messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccine. Conversely, 4 of 5 patients had normal serum histamine and tryptase levels within 2 hours of anaphylaxis.
Source: Annals of Allergy, Asthma and Immunology - February 23, 2022 Category: Allergy & Immunology Authors: Anita Kohli-Pamnani, Kristen Zapata, Tiffany Gibson, Pamela L. Kwittken Tags: Commentary Source Type: research
Hypersentivity reactions to COVID-19 vaccines: a case of Eosinophilic pneumonia following Sinovac/CoronaVac vaccination
Eur Ann Allergy Clin Immunol. 2022 Feb 11. doi: 10.23822/EurAnnACI.1764-1489.247. Online ahead of print.ABSTRACTHypersensitivity reactions has been reported with COVID-19 vaccines. Acute eosinophilic pneumonia has not been reported yet after Sinovac/CoronaVac vaccine. A 73-year-old woman presented with maculopapular rash, cough and dyspnea following Sinovac/CoronaVac injection. The complete blood count (CBC) indicated eosinophilia and further evaluation of the eosinophilia with CT and bronchoscopy confirmed a diagnosis of acute eosinophilic pneumonia. After methylprednisolone therapy, her rash resolved with marked improvem...
Source: European Annals of Allergy and Clinical Immunology - February 14, 2022 Category: Allergy & Immunology Authors: A B Ozturk B Çağlayan M Kapmaz I Çalık S Tekin S İliaz P F ırat Source Type: research
Effectiveness of Coronavirus Vaccines against Syndrome Coronavirus 2 (SARS-CoV-2) and Its New Variants
Iran J Allergy Asthma Immunol. 2021 Dec 8;20(6):647-671. doi: 10.18502/ijaai.v20i6.8016.ABSTRACTThe widespread outbreak of coronavirus disease 2019 in late 2019 caused many people worldwide to die or suffer from certain clinical complications even after the recovery. The virus has many social and economic adverse effects. Studies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have specified that spike, surface glycoprotein antigen, is considered as a major target to stimulate the immune system. This glycoprotein binds to the angiotensin-converting enzyme 2 on the surface of human cells especially lung epit...
Source: Iranian Journal of Allergy, Asthma and Immunology - December 18, 2021 Category: Allergy & Immunology Authors: Afshin Abdi Ghavidel Mahbubeh Rojhannezhad Bahram Kazemi Mojgan Bandehpour Source Type: research
Hypersentivity reactions to COVID-19 vaccines: a case of Eosinophilic pneumonia following Sinovac/CoronaVac vaccination
Eur Ann Allergy Clin Immunol. 2022 Feb 11. doi: 10.23822/EurAnnACI.1764-1489.247. Online ahead of print.ABSTRACTHypersensitivity reactions has been reported with COVID-19 vaccines. Acute eosinophilic pneumonia has not been reported yet after Sinovac/CoronaVac vaccine. A 73-year-old woman presented with maculopapular rash, cough and dyspnea following Sinovac/CoronaVac injection. The complete blood count (CBC) indicated eosinophilia and further evaluation of the eosinophilia with CT and bronchoscopy confirmed a diagnosis of acute eosinophilic pneumonia. After methylprednisolone therapy, her rash resolved with marked improvem...
Source: European Annals of Allergy and Clinical Immunology - February 14, 2022 Category: Allergy & Immunology Authors: A B Ozturk B Çağlayan M Kapmaz I Çalık S Tekin S İliaz P F ırat Source Type: research
Effectiveness of Coronavirus Vaccines against Syndrome Coronavirus 2 (SARS-CoV-2) and Its New Variants
Iran J Allergy Asthma Immunol. 2021 Dec 8;20(6):647-671. doi: 10.18502/ijaai.v20i6.8016.ABSTRACTThe widespread outbreak of coronavirus disease 2019 in late 2019 caused many people worldwide to die or suffer from certain clinical complications even after the recovery. The virus has many social and economic adverse effects. Studies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have specified that spike, surface glycoprotein antigen, is considered as a major target to stimulate the immune system. This glycoprotein binds to the angiotensin-converting enzyme 2 on the surface of human cells especially lung epit...
Source: Iranian Journal of Allergy, Asthma and Immunology - December 18, 2021 Category: Allergy & Immunology Authors: Afshin Abdi Ghavidel Mahbubeh Rojhannezhad Bahram Kazemi Mojgan Bandehpour Source Type: research
Hypersentivity reactions to COVID-19 vaccines: a case of Eosinophilic pneumonia following Sinovac/CoronaVac vaccination
Eur Ann Allergy Clin Immunol. 2022 Feb 11. doi: 10.23822/EurAnnACI.1764-1489.247. Online ahead of print.ABSTRACTHypersensitivity reactions has been reported with COVID-19 vaccines. Acute eosinophilic pneumonia has not been reported yet after Sinovac/CoronaVac vaccine. A 73-year-old woman presented with maculopapular rash, cough and dyspnea following Sinovac/CoronaVac injection. The complete blood count (CBC) indicated eosinophilia and further evaluation of the eosinophilia with CT and bronchoscopy confirmed a diagnosis of acute eosinophilic pneumonia. After methylprednisolone therapy, her rash resolved with marked improvem...
Source: European Annals of Allergy and Clinical Immunology - February 14, 2022 Category: Allergy & Immunology Authors: A B Ozturk B Çağlayan M Kapmaz I Çalık S Tekin S İliaz P F ırat Source Type: research
Effectiveness of Coronavirus Vaccines against Syndrome Coronavirus 2 (SARS-CoV-2) and Its New Variants
Iran J Allergy Asthma Immunol. 2021 Dec 8;20(6):647-671. doi: 10.18502/ijaai.v20i6.8016.ABSTRACTThe widespread outbreak of coronavirus disease 2019 in late 2019 caused many people worldwide to die or suffer from certain clinical complications even after the recovery. The virus has many social and economic adverse effects. Studies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have specified that spike, surface glycoprotein antigen, is considered as a major target to stimulate the immune system. This glycoprotein binds to the angiotensin-converting enzyme 2 on the surface of human cells especially lung epit...
Source: Iranian Journal of Allergy, Asthma and Immunology - December 18, 2021 Category: Allergy & Immunology Authors: Afshin Abdi Ghavidel Mahbubeh Rojhannezhad Bahram Kazemi Mojgan Bandehpour Source Type: research
Coronavirus disease 2019 messenger RNA vaccine skin tests and serum histamine levels in allergic reactions
Ann Allergy Asthma Immunol. 2022 Mar;128(3):339. doi: 10.1016/j.anai.2021.12.014.NO ABSTRACTPMID:35216745 | PMC:PMC8863136 | DOI:10.1016/j.anai.2021.12.014
Source: Annals of Allergy, Asthma and Immunology - February 26, 2022 Category: Allergy & Immunology Authors: Anita Kohli-Pamnani Kristen Zapata Tiffany Gibson Pamela L Kwittken Source Type: research
Immune parameters during anaphylaxis to messenger RNA coronavirus disease 2019 vaccines: Not the usual suspects?
Ann Allergy Asthma Immunol. 2022 Mar;128(3):338-339. doi: 10.1016/j.anai.2021.11.012.NO ABSTRACTPMID:35216744 | PMC:PMC8863137 | DOI:10.1016/j.anai.2021.11.012
Source: Annals of Allergy, Asthma and Immunology - February 26, 2022 Category: Allergy & Immunology Authors: Luc de Chaisemartin Antoine Diep C écile Gonnin Ang èle Soria Annick Barbaud Pascale Nicaise-Roland Source Type: research
Effectiveness of Coronavirus Vaccines against Syndrome Coronavirus 2 (SARS-CoV-2) and Its New Variants
Iran J Allergy Asthma Immunol. 2021 Dec 8;20(6):647-671. doi: 10.18502/ijaai.v20i6.8016.ABSTRACTThe widespread outbreak of coronavirus disease 2019 in late 2019 caused many people worldwide to die or suffer from certain clinical complications even after the recovery. The virus has many social and economic adverse effects. Studies on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have specified that spike, surface glycoprotein antigen, is considered as a major target to stimulate the immune system. This glycoprotein binds to the angiotensin-converting enzyme 2 on the surface of human cells especially lung epit...
Source: Iranian Journal of Allergy, Asthma and Immunology - December 18, 2021 Category: Allergy & Immunology Authors: Afshin Abdi Ghavidel Mahbubeh Rojhannezhad Bahram Kazemi Mojgan Bandehpour Source Type: research
